Showing results (131-140 of 233) with videos related to
Sort By:
Pageof 24
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 27, 2012
Ultrasonic scalpel for gastric cancer surgery: a prospective randomized studyKentaro Inoue, Yasushi Nakane, Taku Michiura, et al.Cancer Chemotherapy and Pharmacology|January 7, 2018
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202)Hiroaki Yanagimoto, Hideyoshi Toyokawa, Daisuke Sakai, et al.Journal of Hepato-Biliary-Pancreatic Sciences|April 19, 2022
Clinical outcomes of organ-preserving pancreatectomy for benign or low-grade malignant pancreatic tumors: A multicenter nationwide survey in JapanYukio Asano, Hiroyuki Kato, Satoshi Arakawa, et al.Journal of Clinical Medicine|May 27, 2023
A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic CancerTatsuki Ikoma, Toshihiko Matsumoto, Shogen Boku, et al.Journal of Hepato-Biliary-Pancreatic Sciences|July 28, 2017
Developing better practices at the institutional level leads to better outcomes after pancreaticoduodenectomy in 3,378 patients: domestic audit of the Japanese Society of Pancreatic SurgerySohei Satoi, Tomohisa Yamamoto, Hideyuki Yoshitomi, et al.Annals of Gastroenterological Surgery|June 5, 2018
Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1515 patients: Domestic audit of the Japanese Society of Pancreatic SurgerySohei Satoi, Tomohisa Yamamoto, Fuyuhiko Motoi, et al.Cancer Chemotherapy and Pharmacology|December 10, 2015
Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinomaHiroaki Yanagimoto, Sohei Satoi, Masayuki Sho, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 31, 2015
Comparison of neutrophil infiltration between type 1 and type 2 autoimmune pancreatitisToshiyuki Mitsuyama, Kazushige Uchida, Kimi Sumimoto, et al.Journal of Hepato-Biliary-Pancreatic Sciences|September 25, 2023
Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04)Teiichi Sugiura, Hirochika Toyama, Akira Fukutomi, et al.World Journal of Surgery|October 10, 2018
Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic AdenocarcinomaFuyuhiko Motoi, Yoshiaki Murakami, Ken-Ichi Okada, et al.Pageof 24